Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Epigenomics | journal | 0.894 Q2 | 77 | 141 | 403 | 7994 | 1725 | 380 | 3.95 | 56.70 | 49.89 | |
52 | Human Cell | journal | 0.868 Q2 | 44 | 184 | 226 | 6480 | 1019 | 217 | 4.40 | 35.22 | 36.37 | |
53 | Leukemia Research | journal | 0.865 Q2 | 96 | 167 | 468 | 4864 | 1211 | 339 | 2.47 | 29.13 | 46.36 | |
54 | Cancer Microenvironment | journal | 0.852 Q2 | 51 | 0 | 31 | 0 | 138 | 29 | 5.56 | 0.00 | 0.00 | |
55 | Cancer Chemotherapy and Pharmacology | journal | 0.848 Q3 | 122 | 174 | 680 | 6355 | 2399 | 669 | 3.31 | 36.52 | 34.82 | |
56 | Infectious Agents and Cancer | journal | 0.837 Q3 | 47 | 69 | 160 | 3477 | 544 | 159 | 3.22 | 50.39 | 46.92 | |
57 | Future Oncology | journal | 0.836 Q3 | 90 | 441 | 1030 | 19469 | 3421 | 960 | 3.34 | 44.15 | 38.20 | |
58 | Cancer Causes and Control | journal | 0.813 Q3 | 147 | 140 | 373 | 5440 | 1044 | 358 | 2.64 | 38.86 | 51.40 | |
59 | Oncology Reports | journal | 0.812 Q3 | 115 | 345 | 1700 | 18205 | 7105 | 1700 | 3.92 | 52.77 | 38.90 | |
60 | Oncology | journal | 0.785 Q3 | 107 | 91 | 310 | 3245 | 1021 | 303 | 3.39 | 35.66 | 29.49 | |
61 | Journal of Oral Pathology and Medicine | journal | 0.774 Q3 | 95 | 127 | 411 | 3812 | 1803 | 388 | 4.38 | 30.02 | 46.58 | |
62 | Clinical and Translational Oncology | journal | 0.764 Q3 | 61 | 264 | 645 | 10494 | 2168 | 617 | 3.35 | 39.75 | 40.99 | |
63 | Cancer Genomics and Proteomics | journal | 0.748 Q3 | 50 | 61 | 176 | 4044 | 738 | 176 | 3.50 | 66.30 | 35.16 | |
64 | Leukemia and Lymphoma | journal | 0.741 Q3 | 102 | 491 | 1496 | 14227 | 2814 | 884 | 1.76 | 28.98 | 44.57 | |
65 | Oncology Reviews | journal | 0.737 Q3 | 31 | 12 | 70 | 793 | 295 | 69 | 3.94 | 66.08 | 51.92 | |
66 | FASEB BioAdvances | journal | 0.713 Q3 | 18 | 91 | 118 | 4595 | 335 | 113 | 2.84 | 50.49 | 40.71 | |
67 | International Journal of Hyperthermia | journal | 0.709 Q3 | 98 | 197 | 601 | 7870 | 2231 | 574 | 3.58 | 39.95 | 36.22 | |
68 | Cancer Biomarkers | journal | 0.688 Q3 | 54 | 123 | 510 | 4721 | 1971 | 510 | 3.62 | 38.38 | 43.63 | |
69 | Japanese Journal of Clinical Oncology | journal | 0.679 Q3 | 95 | 298 | 552 | 7186 | 1562 | 505 | 2.73 | 24.11 | 19.69 | |
70 | Familial Cancer | journal | 0.667 Q3 | 67 | 45 | 184 | 1424 | 413 | 177 | 2.63 | 31.64 | 54.16 | |
71 | ecancermedicalscience | journal | 0.665 Q3 | 47 | 183 | 392 | 6364 | 1182 | 389 | 3.12 | 34.78 | 45.14 | |
72 | Molecular Medicine Reports | journal | 0.650 Q3 | 86 | 812 | 3729 | 38045 | 12771 | 3729 | 3.38 | 46.85 | 43.12 | |
73 | Oncology Letters | journal | 0.639 Q3 | 81 | 815 | 4913 | 38294 | 15170 | 4913 | 3.03 | 46.99 | 38.77 | |
74 | Pathology and Oncology Research | journal | 0.628 Q3 | 61 | 158 | 657 | 6445 | 1799 | 596 | 2.61 | 40.79 | 43.38 | |
75 | Oncology Research and Treatment | journal | 0.624 Q3 | 55 | 92 | 354 | 2410 | 786 | 322 | 1.78 | 26.20 | 35.70 | |
76 | International Journal of Biological Markers | journal | 0.613 Q3 | 47 | 26 | 189 | 858 | 536 | 180 | 2.89 | 33.00 | 38.78 | |
77 | Anticancer Research | journal | 0.596 Q3 | 136 | 706 | 2558 | 23561 | 6420 | 2556 | 2.47 | 33.37 | 27.52 | |
78 | In Vivo | journal | 0.522 Q3 | 72 | 440 | 1033 | 14722 | 2563 | 1033 | 2.41 | 33.46 | 29.67 | |
79 | Cancer Treatment and Research Communications | journal | 0.520 Q3 | 23 | 227 | 161 | 9840 | 314 | 151 | 2.07 | 43.35 | 41.91 | |
80 | Molecular and Cellular Oncology | journal | 0.501 Q4 | 37 | 104 | 334 | 1056 | 477 | 267 | 1.36 | 10.15 | 40.00 | |
81 | Journal of B.U.ON. | journal | 0.478 Q4 | 37 | 440 | 1141 | 11009 | 2377 | 1006 | 2.07 | 25.02 | 40.34 | |
82 | Tumori | journal | 0.407 Q4 | 59 | 115 | 284 | 2651 | 443 | 260 | 1.58 | 23.05 | 43.47 | |
83 | Molecular and Clinical Oncology | journal | 0.393 Q4 | 19 | 262 | 345 | 7685 | 633 | 344 | 1.85 | 29.33 | 28.56 | |
84 | Cancer Reports | journal | 0.320 Q4 | 18 | 117 | 148 | 4337 | 225 | 142 | 1.59 | 37.07 | 36.02 | |
85 | Bulletin du Cancer | journal | 0.284 Q4 | 44 | 214 | 563 | 6488 | 570 | 445 | 0.98 | 30.32 | 51.31 | |
86 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.281 Q4 | 56 | 359 | 1323 | 9590 | 2540 | 793 | 2.00 | 26.71 | 40.19 | |
87 | Breast Disease | journal | 0.269 Q4 | 36 | 56 | 56 | 1806 | 76 | 56 | 1.45 | 32.25 | 43.16 | |
88 | European Journal of Cancer, Supplement | journal | 0.248 Q4 | 29 | 3 | 11 | 75 | 16 | 11 | 1.45 | 25.00 | 40.00 | |
89 | International Journal of Cancer Management | journal | 0.189 Q4 | 26 | 92 | 269 | 2918 | 178 | 263 | 0.58 | 31.72 | 44.44 | |
90 | Progress in Tumor Research | book series | 0.158 Q4 | 12 | 0 | 10 | 0 | 3 | 10 | 0.00 | 0.00 | 0.00 | |
91 | Atlas of Genetics and Cytogenetics in Oncology and Haematology | journal | 0.120 Q4 | 4 | 0 | 279 | 0 | 44 | 279 | 0.14 | 0.00 | 0.00 | |
92 | Gaceta Mexicana de Oncologia | journal | 0.118 Q4 | 7 | 56 | 103 | 1802 | 23 | 93 | 0.16 | 32.18 | 37.66 | |
93 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.103 Q4 | 50 | 0 | 34 | 0 | 1 | 32 | 0.00 | 0.00 | 0.00 | |
94 | Cancer Treatment and Research | journal | 65 | 31 | 110 | 1856 | 308 | 0 | 3.04 | 59.87 | 50.00 | ||
95 | Discover Oncology | journal | 44 | 63 | 85 | 3669 | 376 | 83 | 4.59 | 58.24 | 42.64 | ||
96 | Function | journal | 16 | 79 | 23 | 2834 | 102 | 19 | 4.43 | 35.87 | 36.27 | ||
97 | NAR Cancer | journal | 17 | 53 | 37 | 4464 | 180 | 36 | 4.86 | 84.23 | 44.76 | ||
98 | npj Precision Oncology | journal | 36 | 100 | 93 | 5004 | 1011 | 92 | 9.82 | 50.04 | 39.16 | ||
99 | South Asian Journal of Cancer | journal | 25 | 71 | 191 | 1313 | 210 | 155 | 0.93 | 18.49 | 34.06 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®